Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.09M Buy
130,063
+51,770
+66% +$1.92M 0.01% 1026
2026
Q1
$3.13M Buy
+78,293
New +$3.71M ﹤0.01% 1267
2025
Q4
Sell
-62,223
Closed -$2.78M 3753
2025
Q3
$2.78M Sell
62,223
-32,388
-34% -$1.55M ﹤0.01% 1232
2025
Q2
$4.55M Sell
94,611
-14,908
-14% -$648K 0.01% 909
2025
Q1
$4.4M Sell
109,519
-12,940
-11% -$544K 0.01% 860
2024
Q4
$5.61M Sell
122,459
-2,779
-2% -$124K 0.01% 754
2024
Q3
$5.87M Buy
125,238
+11,745
+10% +$536K 0.01% 725
2024
Q2
$4.8M Buy
113,493
+36,608
+48% +$1.61M 0.01% 742
2024
Q1
$3.4M Buy
76,885
+41,870
+120% +$1.91M 0.01% 875
2023
Q4
$1.61M Buy
35,015
+23,578
+206% +$1M ﹤0.01% 1161
2023
Q3
$491K Sell
11,437
-5,530
-33% -$258K ﹤0.01% 1793
2023
Q2
$810K Buy
16,967
+1,458
+9% +$70.3K ﹤0.01% 1432
2023
Q1
$755K Buy
15,509
+2,068
+15% +$105K ﹤0.01% 1429
2022
Q4
$711K Sell
13,441
-488
-4% -$24.1K ﹤0.01% 1423
2022
Q3
$610K Buy
13,929
+19
+0.1% +$939 ﹤0.01% 1304
2022
Q2
$696K Buy
13,910
+2,429
+21% +$119K ﹤0.01% 1026
2022
Q1
$596K Buy
+11,481
New +$593K ﹤0.01% 1080

Other funds holding QGEN

Mariner's QGEN Position: Q2 2026 in Review

Mariner increased its Qiagen (QGEN) stake by 66% in Q2 2026, buying an estimated $1.92M and bringing the position to 130,063 shares worth $5.09M. The position accounts for 0.01% of the portfolio, ranked #1026.

Mariner first reported a position in QGEN in Q1 2022 and has held it in 17 quarters since. The position peaked at $5.87M in Q3 2024. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Mariner held 130,063 shares of Qiagen worth $5.09M as of Q2 2026.
  • Mariner bought 51,770 Qiagen shares in Q2 2026, an estimated $1.92M.
  • Qiagen made up 0.01% of Mariner's portfolio in Q2 2026, its #1026 holding.
  • Mariner first reported a position in Qiagen in Q1 2022 and has held it in 17 quarters since.
  • Mariner's Qiagen position peaked at $5.87M in Q3 2024.
  • 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.